Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -59.52% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -5.93% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 66.41% vs NA in Mar 2024
Compare Balance Sheet Results of Onyx Biotec
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
18.13
20.00
-1.87
-9.35%
Share Warrants & Outstandings
Total Reserve
37.49
60.57
-23.08
-38.10%
Shareholder's Funds
55.62
80.58
-24.96
-30.98%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
6.76
0.00
6.76
0.00%
Secured Loans
5.49
0.00
5.49
0.00%
Unsecured Loans
1.27
0.00
1.27
0.00%
Deferred Tax Assets / Liabilities
3.14
-0.27
3.41
1,262.96%
Other Long Term Liabilities
0.00
0.30
-0.30
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
9.90
0.03
9.87
32,900.00%
Current Liabilities
Trade Payables
16.73
2.44
14.29
585.66%
Other Current Liabilities
3.30
3.35
-0.05
-1.49%
Short Term Borrowings
5.70
0.00
5.70
0.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
25.73
5.79
19.94
344.39%
Total Liabilities
91.25
86.40
4.85
5.61%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
40.90
2.72
38.18
1,403.68%
Less: Accumulated Depreciation
0.00
1.58
-1.58
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
40.90
1.14
39.76
3,487.72%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.20
-0.20
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
2.51
-2.51
-100.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
1.16
10.74
-9.58
-89.20%
Total Non-Current Assets
42.06
14.60
27.46
188.08%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
16.10
0.83
15.27
1,839.76%
Sundry Debtors
20.23
20.90
-0.67
-3.21%
Cash and Bank
8.61
47.37
-38.76
-81.82%
Other Current Assets
4.07
0.42
3.65
869.05%
Short Term Loans and Advances
0.17
2.28
-2.11
-92.54%
Total Current Assets
49.19
71.80
-22.61
-31.49%
Net Current Assets (Including Current Investments)
23.46
66.01
-42.55
-64.46%
Total Current Assets Excluding Current Investments
49.19
71.80
-22.61
-31.49%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
91.25
86.40
4.85
5.61%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
12.46
0.00
12.46
0.00%
Book Value per share (adjusted)
30.68
40.28
-9.60
-23.83%
Annual - Borrowings
Borrowings 12.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -59.52% vs NA in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 40.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.93% vs NA in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 49.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.41% vs NA in Mar 2024






